Trityl Olmesartan Ethyl Ester CAS 144690-33-5 Pite> 98.5% (HPLC) Faktori

Deskripsyon kout:

Non Chimik: Trityl Olmesartan Ethyl Ester

CAS: 144690-33-5

Pite:> 98.5% (HPLC)

Aparans: poud blan ak blan

Segondè Kalite, Pwodiksyon Komèsyal

E-Mail: alvin@ruifuchem.com


Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Deskripsyon:

Pwopriyete chimik:

Non Chimik Trityl Olmesartan Ethyl Ester
Sinonim Olmesartan Ethyl Ester Trityl Enpurte;Olmesartan Medoxomil enpurte 30;4-(1-Idroksi-1-Methylethyl)-2-propyl-1-[[2'-[1-(Triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl ]methyl]-1H-Imidazol-5-carboxylic Asid Ethyl Ester;Etil 4-(2-hydroxypropan-2-yl)-2-Propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) )methyl)-1H-imidazol-5-carboxylate
Nimewo CAS 144690-33-5
Nimewo CAT RF-PI1873
Estati Stock Nan Stock, Pwodiksyon Echèl Jiska Tòn
Fòmil molekilè C45H44N6O3
Pwa molekilè 716.87
Pwen k ap fonn 161℃
Dansite 1.18±0.1 g/cm3
Mak Ruifu Chimik

Espesifikasyon:

Atik Espesifikasyon
Aparans Poud blan pou blan
Pite / Metòd analiz >98.5% (HPLC)
Kontni dlo (KF) <0.50%
Rezid sou ignisyon <0.20%
Enpurte Ⅰ <0.10% 4-(1-Hydroxy-1-methylpropyl)-2-propyl-1-{[2'-(triphenylmethyl)-1H-tetrazol-5-yl] [1,1'-biphenyl]-4-yl ]methyl}-1H-imidazol-5-carboxylic etil ester
Enpurte Ⅱ <0.10% 4-(1-Methoxy-1-methylethyl)-2-propyl-1-{[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl] [1,1'-biphenyl]- 4-yl]methyl}-1H-imidazol-5-carboxylic etil ester
Enpurte Ⅲ <0.50% 4-isopropenyl-2-propyl-1-{[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl] [1,1'-biphenyl]-4-yl]methyl}-1H -imidazol-5-carboxylic ethyl ester
Lòt Maksimòm Single Enpurte <1.00%
Enpurte total <1.50%
Tès Creole Enterprise Standard

Pake & Depo:

Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite

Avantaj:

1

FAQ:

Aplikasyon:

Trityl Olmesartan Ethyl Ester (CAS: 144690-33-5) se yon enpurte nan Olmesartan Medoxomil (CAS: 144689-63-4).Olmesartan Medoxomil se yon antagonis reseptè anjyotansin II ki itilize pou trete tansyon wo, ki itilize kòm yon dwòg anti-ipètansif.Olmesartan travay lè li bloke anjyotansin II ak reseptè AT1 nan misk vaskilè yo.Pa bloke lyezon an olye ke sentèz angiotensin II, Olmesartan inibit fidbak negatif regilasyon sou sekresyon renin.Olmesartan Medoxomil te lanse Ozetazini kòm Benicar@, yon tretman oral pou tansyon wo.Olmesartan Medoxomil se rapidman ak konplètman bioaktive pa idroliz ester nan metabolit aktif li yo, olmesartan, pandan absòpsyon nan aparèy gastwoentestinal la.

Ekri mesaj ou la a epi voye l ba nou